| Modifier | Description |
|---|---|
| J1 | Competitive acquisition program no-pay submission for a prescription number |
| J2 | Competitive acquisition program, restocking of emergency drugs after emergency administration |
| J3 | Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology |
| J4 | Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge |
| J5 | Off-the-shelf orthotic subject to dmepos competitive bidding program that is furnished as part of a physical therapist or occupational therapist professional service |
| JA | Administered intravenously |
| JB | Administered subcutaneously |
| JC | Skin substitute used as a graft |
| JD | Skin substitute not used as a graft |
| JE | Administered via dialysate |
| JF | Compounded drug Terminated June 30, 2015. |
| JG | Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes |
| JK | One month supply or less of drug or biological |
| JL | Three month supply of drug or biological |
| JW | Drug amount discarded/not administered to any patient |
| JZ | Zero drug amount discarded/not administered to any patient |